Tachycardia-induced cardiomyopathy

American Journal of Medicine

Volumn 114, Issue 1, 2003, Pages 51-55

  Umana, Ernesto ^a,d   Solares, C Arturo ^b   Alpert, Martin A ^c  

^a UNIVERSITY OF SOUTH ALABAMA COLLEGE OF MEDICINE   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c ST JOHN S MERCY MEDICAL CENTER   (United States)

^d Ohio Valley Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CARDIOMYOPATHY; CLINICAL FEATURE; HEART ATRIUM ARRHYTHMIA; HEART FAILURE; HEART LEFT VENTRICLE; HEART RATE; HEART VENTRICLE ARRHYTHMIA; HUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; TACHYCARDIA;

EID: 0037252077     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(02)01472-9     Document Type: Article

References (65)

1. Gossage A.M., Braxton Hicks J.A. On auricular fibrillation. QJM. 6:1913;435-440.
2. Brill I.C. Auricular fibrillation with congestive failure and no other evidence of organic heart disease. Am Heart J. 13:1937;175-182.
3. Whipple G.H., Sheffield L.T., Woodman E.G., et al. Reversible congestive heart failure due to chronic rapid stimulation of the normal heart. Proc N Engl Cardiovasc Soc. 20:1962;39-40.
4. Zupan I., Rakovec P., Budihna N., et al. Tachycardia induced cardiomyopathy in dogs relation between chronic supraventricular and chronic ventricular tachycardia . Int J Cardiol. 56:1996;75-81.
5. Armstrong P., Stopps T., Ford S., et al. Rapid ventricular pacing in the dog pathophysiologic studies of heart failure . Circulation. 74:1986;1075-1084.
6. Wilson J., Douglas P., Hickey W., et al. Experimental congestive heart failure produced by rapid ventricular pacing in the dog cardiac effects . Circulation. 75:1987;857-867.
7. Spinale F., Hendrick D., Crawford F., et al. Chronic supraventricular tachycardia causes ventricular dysfunction and subendocardial injury in swine. Am J Physiol. 259:1990;H218-H229.
8. Scott B., Sharma M., Levett J.M., et al. Cardiac geometry and mass changes associated with pacing induced cardiomyopathy in the dog. Am Heart J. 125:1993;1047-1053.
9. Zipes D.P. Atrial fibrillation. A tachycardia-induced atrial cardiomyopathy. Circulation. 95:1997;562-564.
10. Grogan M., Smith H.C., Gersh B.J., Wood D.L. Left ventricular dysfunction due to atrial fibrillation in patients initially believed to have idiopathic dilated cardiomyopathy. Am J Cardiol. 69:1992;1570-1573.
11. Shapiro W., Klein G. Alterations in cardiac function immediately following electrical conversion of atrial fibrillation to normal sinus rhythm. Circulation. 38:1968;1074-1084.
12. Kieny J.R., Sacrez A., Facello A., et al. Increase in radionuclide left ventricular ejection fraction after cardioversion of chronic atrial fibrillation in idiopathic dilated cardiomyopathy. Eur Heart J. 13:1992;1290-1295.
13. Van Gelder I.C., Crijns H.S., Blanksma P.K., et al. Time course of hemodynamic changes and improvement of exercise tolerance after cardioversion of chronic atrial fibrillation unassociated with cardiac valve disease. Am J Cardiol. 72:1993;560-566.
14. Twidale N., Sutton K., Bartlett C., et al. Effects on cardiac performance of the atrioventricular node catheter ablation using radiofrequency current for drug-refractory atrial arrhythmias. Pacing Clin Electrophysiol. 16:1993;1275-1284.
15. Brignole M., Gianfranchi L., Menozzi C., et al. Influence of atrioventricular junction radiofrequency ablation in patients with chronic atrial fibrillation and flutter on the quality of life and cardiac performance. Am J Cardiol. 74:1994;242-246.
16. Rodriguez L.M., Smeets J.L., Xie B., et al. Improvement in left ventricular function by ablation of atrioventricular nodal conduction in selected patients with lone atrial fibrillation. Am J Cardiol. 72:1993;1137-1141.
17. Velasquez Rodriguez E., Martinez Enriquez A. Dilated cardiomyopathy induced by ectopic atrial tachycardia. Arch Inst Cardiol Mex. 70:2000;292-300.
18. Dhala A., Thomas J.P. Images in cardiovascular medicine. Reversible tachycardia-induced cardiomyopathy. Circulation. 95:1997;2327-2328.
19. Gillette P., Wampler D., Garson A., et al. Treatment of atrial automatic tachycardia by ablation procedures. J Am Coll Cardiol. 6:1985;405-409.
20. Rinaldi C.A., Thompson D.S. Tachycardia-induced cardiomyopathy caused by atrial flutter responding to DC cardioversion. Hosp Med. 60:1999;305-306.
21. Luchsinger J.A., Steinberg J.S. Resolution of cardiomyopathy after ablation of atrial flutter. J Am Coll Cardiol. 32:1998;205-210.
22. Sanchez Fernandez-Bernal C., Benito Bartolome F. Reversibility of myocardiopathy induced by incessant supraventricular tachycardia in children after radiofrequency ablation. Rev Esp Cardiol. 50:1997;643-649.
23. Villain E., Vetter V., Garcia J.M., et al. Evolving concepts in the management of congenital junctional ectopic tachycardia a multicenter study . Circulation. 16:1990;681-685.
24. Anselme F., Boyle N., Josephson M. Incessant fascicular tachycardia a cause of arrhythmia induced cardiomyopathy . Pacing Clin Electrophysiol. 21:1998;760-763.
25. Chugh S.S., Shen W.K., Luria D.M., Smith H.C. First evidence of premature ventricular complex-induced cardiomyopathy a potentially reversible cause of heart failure . J Cardiovasc Electrophysiol. 11:2000;328-329.
26. Vijgen J., Hill P., Biblo L.A., Carlson M.D. Tachycardia-induced cardiomyopathy secondary to right ventricular outflow tract ventricular tachycardia improvement of left ventricular systolic function after radiofrequency catheter ablation of the arrhythmia . J Cardiovasc Electrophysiol. 8:1997;445-450.
27. Coleman H.N., Taylor R.R., Pool P.E., et al. Congestive heart failure following chronic tachycardia. Am Heart J. 81:1971;790-798.
28. Ohno M., Cheng C.P., Little W.C. Mechanism of altered patterns of left ventricular filling during the development of congestive heart failure. Circulation. 89:1994;2241-2250.
29. Moe G.W., Stopps T.P., Angus C., et al. Alterations in serum sodium in relation to atrial natriuretic factor and other neuroendocrine variables in experimental pacing-induced heart failure. J Am Coll Cardiol. 13:1989;173-179.
30. Shannon R.P., Komamura K., Stambler B.S., et al. Alterations in myocardial contractility in conscious dogs with dilated cardiomyopathy. Am J Physiol. 260:1991;H1903-H1911.
31. Spinale F.G., Tomita M., Zellner J.L., et al. Collagen remodeling and changes in LV function during development and recovery from supraventricular tachycardia. Am J Physiol. 261:1991;H308-H318.
32. O'Brien P.J., Ianuzzo C.D., Moe G.W., et al. Rapid ventricular pacing in dogs to heart failure biochemical and physiological studies . Can J Physiol Pharmacol. 68:1990;34-39.
33. Komamura K., Shannon R.P., Ihara T., et al. Exhaustion of Frank-Starling mechanism in conscious dogs with heart failure. Am J Physiol. 265:1993;H1119-H1131.
34. Calderone A., Bouvier M., Li K., et al. Dysfunction of the beta- and alpha-adrenergic systems in a model of congestive heart failure. The pacing-overdrive dog. Circ Res. 69:1991;332-343.
35. Marzo K.P., Frey M.J., Wilson J.R., et al. Beta-adrenergic receptor-G protein-adenylate cyclase complex in experimental canine congestive heart failure produced by rapid ventricular pacing. Circ Res. 69:1991;1546-1556.
36. Spinale F.G., Grine R.C., Tempel G.E., et al. Alterations in myocardial capillary vasculature accompany tachycardia-induced cardiomyopathy. Basic Res Cardiol. 87:1992;65-79.
37. Shannon R.P., Komamura K., Shen Y.T., et al. Impaired regional subendocardial coronary flow reserve in conscious dogs with pacing-induced heart failure. Am J Physiol. 265:1993;H801-H809.
38. Perreault C.L., Shannon R.P., Komamura K., et al. Abnormalities in intracellular calcium regulation and contractile function in myocardium from dogs with pacing-induced heart failure. J Clin Invest. 89:1992;932-938.
39. Edner M., Caidahl K., Bergfeldt L., et al. Prospective study of left ventricular function after radiofrequency ablation of atrioventricular junction in patients with atrial fibrillation. Br Heart J. 74:1995;261-267.
40. Twidale N., McDonald T., Nave K., Seal A. Comparison of the effects of AV nodal ablation versus AV nodal modification in patients with congestive heart failure and uncontrolled atrial fibrillation. Pacing Clin Electrophysiol. 21:1998;641-651.
41. Morady F., Hasse C., Strickberger S.A., et al. Long term follow up after radiofrequency modification of the atrioventricular node in patients with atrial fibrillation. J Am Coll Cardiol. 29:1997;113-121.
42. Geelen P., Goethals M., de Bruyne B., Brugada P. A prospective hemodynamic evaluation of patients with chronic atrial fibrillation undergoing radiofrequency catheter ablation of the atrioventricular junction. Am J Cardiol. 80:1997;1606-1609.
43. Brown C.S., Mills R.M. Jr, Conti J.B., Curtis A.B. Clinical improvement after atrioventricular nodal ablation for atrial fibrillation does not correlate with improved ejection fraction. Am J Cardiol. 80:1997;1090-1091.
44. Rosenqvist M. Prospective study of left ventricular function after radiofrequency ablation of atrioventricular junction in patients with atrial fibrillation. Br Heart J. 74:1995;261-267.
45. LeRoy E.R., Wang P.J., Couper G.L., Friedman P.L. Time course of improvement in ventricular function after ablation of incessant autonomic atrial tachycardia. Am Heart J. 121:1991;816-819.
46. Chiladakis J.A., Vassilikos V.P., Maounis T.N., et al. Successful radiofrequency catheter ablation of automatic atrial tachycardia with regression of the cardiomyopathy picture. Pacing Clin Electrophysiol. 20:1997;953-959.
47. Kim Y.H., Goldberger J., Kadish A. Treatment of ventricular tachycardia-induced cardiomyopathy by transcatheter radiofrequency ablation. Heart. 76:1996;550-552.
48. Singh B., Kaul U., Talwar K.K., et al. Reversibility of tachycardia induced cardiomyopathy following the cure of idiopathic ventricular tachycardia using radiofrequency energy. Pacing Clin Electrophysiol. 19:1996;1391-1392.
49. Grimm W., Menz V., Hoffman J., Maisch B. Reversal of tachycardia induced cardiomyopathy following ablation of repetitive monomorphic right ventricular outflow tract tachycardia. Pacing Clin Electrophysiol. 24:2001;166-171.
50. Jaggarao N.S.V., Nanda A.S., Daubert J.P. Ventricular tachycardia induced cardiomyopathy Improvement with radiofrequency ablation . Pacing Clin Electrophysiol. 19:1996;505-508.
51. Matsuura Y., Chin W., Kurihara T. Tachycardia induced cardiomyopathy. A case report. J Cardiol. 20:1990;509-518.
52. Krapp M., Gembruch U., Bauman P. Venous blood flow pattern suggesting tachycardia induced cardiomyopathy in the fetus. Ultrasound Obstet Gynecol. 10:1997;32-40.
53. Sanchez C., Benito F., Moreno F. Reversibility of tachycardia induced cardiomyopathy after radiofrequency ablation of incessant supraventricular tachycardia in infants. Br Heart J. 74:1995;332-333.
54. De Giovanni J.V., Dindar A., Griffith M.J., et al. Recovery pattern of left ventricular dysfunction following ablation of incessant supraventricular tachycardia in infants and children. Heart. 79:1998;588-592.
55. Sanchez Fernandez-Bernal C., Benito-Bartolome F. Reversibilidad de la miocardiopatia inducida por taquicardia supraventricular incesante en ninos tras ablacion con radiofrecuencia. Rev Esp Cardiol. 50:1997;643-649.
56. Redfield M.M., Kay G.N., Jenkins L.S., et al. Tachycardia-related cardiomyopathy a common cause of ventricular dysfunction in patients with atrial fibrillation referred for atrioventricular ablation . Mayo Clin Proc. 75:2000;790-795.
57. Fuster V., Ryden L.A., Asinger R.W., et al. ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation executive summary . J Am Coll Cardiol. 38:2001;1231-1266.
58. Chugh S.S., Shen W., Luria D.M., Smith H.C. First evidence of premature ventricular complex-induced cardiomyopathy a potentially reversible cause of heart failure . J Cardiovasc Electrophysiol. 11:2000;328-329.
59. Aronow W.S., Ahn C., Kronzon I. Echocardiographic findings associated with atrial fibrillation in 1699 patients aged >60 years. Am J Cardiol. 76:1995;1191-1192.
60. Phillips E., Levine S.A. Auricular fibrillation without other evidence of heart disease a cause of reversible heart failure . Am J Med. 7:1949;478-489.
61. Sarter B.H., Marchlinski F.E. Redefining the role of digoxin in the treatment of atrial fibrillation. Am J Cardiol. 69:1992;71G-81G.
62. Hohnloser S.H., Kuck K.H., Lilienthal J., et al. Rhythm or rate control in atrial fibrillation-Pharmacological Intervention in Atrial Fibrillation (PIAF) a randomized trial . Lancet. 356:2000;1789-1794.
63. Williams E.S., Miller J.M. Results from late-breaking clinical trial sessions at the American College of Cardiology 51st Annual Scientific Session. J Am Coll Cardiol. 40:2002;1-18.
64. Louis A., Cleland J.G., Crabbe S., et al. Clinical Trials Update CAPRICORN, COPERNICUS, MIRACLE, STAF, RITZ-2, RECOVER, and RENAISSANCE and cachexia and cholesterol in heart failure. Highlights of the Scientific Sessions of the American College of Cardiology . Eur J Heart Fail. 3:2001;381-387.
65. Shih-Huang L.L., Shinn-Ann C., Ching-Tat T., et al. Comparisons of quality of life and cardiac performance after complete atrioventricular junction ablation and atrioventricular junction modification in patients with medically refractory atrial fibrillation. J Am Coll Cardiol. 31:1998;637-644.